Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Operating Income: 2023-2024

Historic Operating Income for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to -$77.8 million.

  • Upstream Bio's Operating Income fell 100.25% to -$37.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$140.5 million, marking a year-over-year decrease of 113.62%. This contributed to the annual value of -$77.8 million for FY2024, which is 93.86% down from last year.
  • Latest data reveals that Upstream Bio reported Operating Income of -$77.8 million as of FY2024, which was down 93.86% from -$40.1 million recorded in FY2023.
  • Upstream Bio's 5-year Operating Income high stood at -$40.1 million for FY2023, and its period low was -$77.8 million during FY2024.
  • Its 2-year average for Operating Income is -$58.9 million, with a median of -$58.9 million in 2023.
  • Data for Upstream Bio's Operating Income shows a maximum YoY slumped of 93.86% (in 2024) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Operating Income (Yearly) stood at -$40.1 million in 2023, then plummeted by 93.86% to -$77.8 million in 2024.